Diagnosis and Treatment of Patients With Femoroacetabular Impingement Syndrome
Optimization of the Diagnostic Process and Physiotherapist-led Treatment of Patients With Femoroacetabular Impingement Syndrome: a Prospective Cohort Study
1 other identifier
interventional
110
1 country
1
Brief Summary
This prospective study with a two-group comparison design investigates the effectiveness of 12-weeks of semi-structured and supervised physiotherapist-led treatment on self-reported hip and groin function in patients with femoroacetabular impingement syndrome with and without intra-articular hip pain. Determination of intra-articular hip pain is based on pain relief following an ultrasound-guided intra-articular anesthetic hip injection performed prior to commencing treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 18, 2019
CompletedFirst Posted
Study publicly available on registry
February 20, 2019
CompletedStudy Start
First participant enrolled
March 12, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 12, 2021
CompletedJuly 28, 2020
July 1, 2020
2 years
February 18, 2019
July 27, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Change in HAGOS Sport subscale
The primary outcome measure is the between-group (intra-articular pain vs. no intra-articular pain) difference in change in self-reported hip and groin function, measured with the Copenhagen Hip and Groin Outcome Score (HAGOS) Sport subscale from baseline to follow-up in subjects diagnosed with FAIS. The HAGOS Sport subcale is scored on a scale from 0 (extreme hip and groin problems) to 100 (no hip and groin problems).
12 weeks
Secondary Outcomes (8)
Change in HAGOS subscales
12 weeks
Change in hip peak torque
12 weeks
Change in hip rate of torque development
12 weeks
Change in single leg hop performance
12 weeks
Change in isometric adduction squeeze torque
12 weeks
- +3 more secondary outcomes
Study Arms (2)
FAIS with intra-articular hip pain
EXPERIMENTAL12-week of semi-standardized, progressive physiotherapist-led treatment supervised by a physiotherapist blinded to clinical and objective findings. The treatment program will consist of one weekly exercise training session at Hvidovre Hospital supervised by a physiotherapist and twice-weekly unsupervised exercise training sessions performed at home for a consecutive period of 12-weeks (12 supervised sessions; 24 unsupervised sessions). In conjunction with the physiotherapist-led treatment, participants will be advised to modify potential aggravating physical activitie, and gradually increase their level of activity during the treatment period.
FAIS without intra-articular hip pain
EXPERIMENTAL12-week of semi-standardized, progressive physiotherapist-led treatment supervised by a physiotherapist blinded to clinical and objective findings. The treatment program will consist of one weekly exercise training session at Hvidovre Hospital supervised by a physiotherapist and twice-weekly unsupervised exercise training sessions performed at home for a consecutive period of 12-weeks (12 supervised sessions; 24 unsupervised sessions). In conjunction with the physiotherapist-led treatment, participants will be advised to modify potential aggravating physical activitie, and gradually increase their level of activity during the treatment period.
Interventions
12-week of semi-standardized, progressive physiotherapist-led treatment aiming to increase hip muscle strength and load capacity.
Eligibility Criteria
You may qualify if:
- Activity-related longstanding hip and/or groin pain for \>3 months
- Known anterior and/or medial groin pain during the FADIR test with a pain severity of ≥2/10 on NRS.
- Radiological findings on plain radiographs of cam morphology defined as alpha angle \>55° on a lateral view.
You may not qualify if:
- Inguinal-related groin pain diagnosed according to Doha Agreement.
- Pubic-related groin pain diagnosed according to Doha Agreement.
- Evidence of pre-existing hip osteoarthritis, defined as a joint space width \<3 mm at the lateral sourcil on anterior-posterior pelvic radiograph.
- Previous hip pathology such as Perthes' disease, slipped upper femoral epiphysis, hip dysplasia defined as a Lateral Center Edge Angle \<25°, or avascular necrosis.
- Other causes of hip and groin pain identified by the orthopedic surgeon during the clinical examination, such as stress fracture of the femoral neck, referred pain from the facet joint, referred pain from the sacroiliac joint, or other competing diagnosis (rheumatoid arthritis, cancer etc.)
- Previous hip injury such as acetabular fracture, hip dislocation, or femoral neck fracture.
- Previous intra- or extra-articular hip surgery.
- Pregnant.
- Intra-articular steroid hip injection during the preceding 3 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hvidovre University Hospitallead
- La Trobe Universitycollaborator
- Duke Universitycollaborator
Study Sites (1)
All part of the study is conducted at Department of Orthopedic Department, Hvidovre Hospital
Copenhagen, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lasse Ishøi
Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital
- STUDY DIRECTOR
Per Hölmich
Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital
- STUDY DIRECTOR
Kristian Thorborg
Sports Orthopedic Research Center - Copenhagen (SORC-C), Hvidovre Hospital
- STUDY CHAIR
Joanne Kemp
La Trobe Sport and Exercise Medicine Research Centre, La Trobe University
- STUDY CHAIR
Michael Reiman
Duke University Medical Center, Duke University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- Participants will be blinded to the potential value of the diagnostic findings, such as response to intra-articular hip injection. Outcome assessor will be blinded to diagnostic findings, such as response to intra-articular hip injection. Care Provider (Physiotherapist supervising the intervention) will be blinded to diagnostic findings, such as response to intra-articular hip injection.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 18, 2019
First Posted
February 20, 2019
Study Start
March 12, 2019
Primary Completion
March 12, 2021
Study Completion
March 12, 2021
Last Updated
July 28, 2020
Record last verified: 2020-07